Correlation Between Karuna Therapeutics and Arvinas
Can any of the company-specific risk be diversified away by investing in both Karuna Therapeutics and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karuna Therapeutics and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karuna Therapeutics and Arvinas, you can compare the effects of market volatilities on Karuna Therapeutics and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karuna Therapeutics with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karuna Therapeutics and Arvinas.
Diversification Opportunities for Karuna Therapeutics and Arvinas
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Karuna and Arvinas is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Karuna Therapeutics and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Karuna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karuna Therapeutics are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Karuna Therapeutics i.e., Karuna Therapeutics and Arvinas go up and down completely randomly.
Pair Corralation between Karuna Therapeutics and Arvinas
If you would invest 2,550 in Arvinas on September 3, 2024 and sell it today you would earn a total of 122.00 from holding Arvinas or generate 4.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 1.56% |
| Values | Daily Returns |
Karuna Therapeutics vs. Arvinas
Performance |
| Timeline |
| Karuna Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Arvinas |
Karuna Therapeutics and Arvinas Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Karuna Therapeutics and Arvinas
The main advantage of trading using opposite Karuna Therapeutics and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karuna Therapeutics position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.| Karuna Therapeutics vs. Blueprint Medicines Corp | Karuna Therapeutics vs. Amylyx Pharmaceuticals | Karuna Therapeutics vs. Day One Biopharmaceuticals | Karuna Therapeutics vs. X4 Pharmaceuticals |
| Arvinas vs. C4 Therapeutics | Arvinas vs. Monte Rosa Therapeutics | Arvinas vs. Nurix Therapeutics | Arvinas vs. Foghorn Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |